Efficacy and Safety of Concizumab prophylaxis in patients with haemophilia A or B with inhibitors CTMS#: 19-0130
Lay Description
Category
- IRB Number
- 20190627HU
- NCT Number
- ct.gov registration not required
- Open to Enrollment
- Yes
Eligibility
- Eligible Ages
- Eligible Genders
- Accepts Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Study Design
Arm Groups
Study Contact
Melissa Frei-Jones
(210) 567-7477
freijones@uthscsa.edu
Shawn Lade
+1 (210) 450-8965
lade@uthscsa.edu
Melissa Frei-Jones
(210) 567-7477
freijones@uthscsa.edu
Principal Investigator
Melissa Frei-Jones